Cargando…

Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma

IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xi, Huang, Xiaodong, Liu, Shaoyan, Wang, Xiaolei, Luo, Jingwei, Xiao, Jianping, Wang, Kai, Qu, Yuan, Chen, Xuesong, Zhang, Ye, Wang, Jingbo, Zhang, Jianghu, Xu, Guozhen, Gao, Li, Wu, Runye, Yi, Junlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864511/
https://www.ncbi.nlm.nih.gov/pubmed/35191967
http://dx.doi.org/10.1001/jamanetworkopen.2022.0165
_version_ 1784655475844841472
author Luo, Xi
Huang, Xiaodong
Liu, Shaoyan
Wang, Xiaolei
Luo, Jingwei
Xiao, Jianping
Wang, Kai
Qu, Yuan
Chen, Xuesong
Zhang, Ye
Wang, Jingbo
Zhang, Jianghu
Xu, Guozhen
Gao, Li
Wu, Runye
Yi, Junlin
author_facet Luo, Xi
Huang, Xiaodong
Liu, Shaoyan
Wang, Xiaolei
Luo, Jingwei
Xiao, Jianping
Wang, Kai
Qu, Yuan
Chen, Xuesong
Zhang, Ye
Wang, Jingbo
Zhang, Jianghu
Xu, Guozhen
Gao, Li
Wu, Runye
Yi, Junlin
author_sort Luo, Xi
collection PubMed
description IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resectable LAHPC. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted from May 2009 to October 2019 with a median (IQR) follow-up period of 66.5 (44.7-97.0) months. The study was conducted at a tertiary academic medical center and included 423 patients pathologically confirmed stage III and IVB LAHPC. A total of 250 patients with previous cancer history, synchronous primary cancer, stage I or II, or with unresectable hypopharyngeal carcinoma were excluded. EXPOSURES: Patients who reached 80% or greater tumor regression when evaluated endoscopically and by imaging methods at 50 Gy received definitive RT or concurrent chemoradiotherapy, and those with less than 80% regression underwent surgery 4 to 6 weeks after RT. MAIN OUTCOMES AND MEASURES: Five-year overall survival and survival with a functional larynx. RESULTS: Overall, 423 patients were included in the study (median [IQR] age, 55 [50-63] years; 408 [96.5%] men and 15 [3.5%] women). The response-adapted and primary surgery groups had significantly better survival than the primary RT group (52.7% and 54.4% vs 27.7%, respectively; P < .001). The response-adapted and primary surgery groups had similar 5-year overall survival of 52.7% vs 54.4%, respectively (hazard ratio [HR], 1.02; 95% CI, 0.75 to 1.39; P = .89). The response-adapted group had better 5-year survival with functional larynx than the primary surgery group (40.6% vs 33.9%; HR, 0.64; 95% CI, 0.49 to 0.84, P = .001). Surgery complications did not significantly differ between the 2 groups. Among patients in the response-adapted group who required total laryngectomy (n = 186) as indicated by pretreatment evaluation, the 5-year cumulative Kaplan-Meier survival with functional larynx was 39.8%. CONCLUSIONS AND RELEVANCE: In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, maximum tumor control, and higher laryngeal preservation compared with primary surgery and primary RT strategies. This approach could provide a feasible laryngeal preservation strategy in patients with LAHPC.
format Online
Article
Text
id pubmed-8864511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-88645112022-03-04 Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma Luo, Xi Huang, Xiaodong Liu, Shaoyan Wang, Xiaolei Luo, Jingwei Xiao, Jianping Wang, Kai Qu, Yuan Chen, Xuesong Zhang, Ye Wang, Jingbo Zhang, Jianghu Xu, Guozhen Gao, Li Wu, Runye Yi, Junlin JAMA Netw Open Original Investigation IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resectable LAHPC. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted from May 2009 to October 2019 with a median (IQR) follow-up period of 66.5 (44.7-97.0) months. The study was conducted at a tertiary academic medical center and included 423 patients pathologically confirmed stage III and IVB LAHPC. A total of 250 patients with previous cancer history, synchronous primary cancer, stage I or II, or with unresectable hypopharyngeal carcinoma were excluded. EXPOSURES: Patients who reached 80% or greater tumor regression when evaluated endoscopically and by imaging methods at 50 Gy received definitive RT or concurrent chemoradiotherapy, and those with less than 80% regression underwent surgery 4 to 6 weeks after RT. MAIN OUTCOMES AND MEASURES: Five-year overall survival and survival with a functional larynx. RESULTS: Overall, 423 patients were included in the study (median [IQR] age, 55 [50-63] years; 408 [96.5%] men and 15 [3.5%] women). The response-adapted and primary surgery groups had significantly better survival than the primary RT group (52.7% and 54.4% vs 27.7%, respectively; P < .001). The response-adapted and primary surgery groups had similar 5-year overall survival of 52.7% vs 54.4%, respectively (hazard ratio [HR], 1.02; 95% CI, 0.75 to 1.39; P = .89). The response-adapted group had better 5-year survival with functional larynx than the primary surgery group (40.6% vs 33.9%; HR, 0.64; 95% CI, 0.49 to 0.84, P = .001). Surgery complications did not significantly differ between the 2 groups. Among patients in the response-adapted group who required total laryngectomy (n = 186) as indicated by pretreatment evaluation, the 5-year cumulative Kaplan-Meier survival with functional larynx was 39.8%. CONCLUSIONS AND RELEVANCE: In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, maximum tumor control, and higher laryngeal preservation compared with primary surgery and primary RT strategies. This approach could provide a feasible laryngeal preservation strategy in patients with LAHPC. American Medical Association 2022-02-22 /pmc/articles/PMC8864511/ /pubmed/35191967 http://dx.doi.org/10.1001/jamanetworkopen.2022.0165 Text en Copyright 2022 Luo X et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Luo, Xi
Huang, Xiaodong
Liu, Shaoyan
Wang, Xiaolei
Luo, Jingwei
Xiao, Jianping
Wang, Kai
Qu, Yuan
Chen, Xuesong
Zhang, Ye
Wang, Jingbo
Zhang, Jianghu
Xu, Guozhen
Gao, Li
Wu, Runye
Yi, Junlin
Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title_full Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title_fullStr Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title_full_unstemmed Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title_short Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
title_sort response-adapted treatment following radiotherapy in patients with resectable locally advanced hypopharyngeal carcinoma
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864511/
https://www.ncbi.nlm.nih.gov/pubmed/35191967
http://dx.doi.org/10.1001/jamanetworkopen.2022.0165
work_keys_str_mv AT luoxi responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT huangxiaodong responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT liushaoyan responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT wangxiaolei responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT luojingwei responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT xiaojianping responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT wangkai responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT quyuan responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT chenxuesong responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT zhangye responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT wangjingbo responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT zhangjianghu responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT xuguozhen responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT gaoli responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT wurunye responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma
AT yijunlin responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma